PTC Therapeutics, Inc. (PTCT)

63.98
0.45 0.71
NASDAQ
Prev Close 63.53
Open 64.00
Day Low/High 63.28 / 64.61
52 Wk Low/High 30.79 / 64.62
Volume 245.48K
Exchange NASDAQ
Shares Outstanding 68.24B
Market Cap 4.34B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Flexion Shares Continue Rise After FDA Approval -- Biotech Movers

Flexion Shares Continue Rise After FDA Approval -- Biotech Movers

Burlington, Mass.-based Flexion Therapeutics said Friday it has receive FDA approval for osteoarthritis knee pain treatment Zilretta, a non-opioid medicine utilizing Flexion's microsphere technology.

Could These 9 Drugs Gain FDA Approval in the Age of Trump?

Could These 9 Drugs Gain FDA Approval in the Age of Trump?

Nine biotech and drug companies want FDA approval, but need changed standards to get it.

The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

The firms all have drugs they want the feds to bend the rules to approve.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Materials, financials, cyclicals and health care names tilt the scale to the bullish side.

More Stocks to Watch on A Slow Day

It's a very boring session with a narrow trading range as investors take break after four days of rally mode to digest Federal Reserve Chair Janet Yellen's latest comments. Some stocks of interest: Barclays moved Las Vegas Sands (LVS) to Overweight ...

PTC Therapeutics upgraded at JP Morgan

Out on a Positive Note

Out on a Positive Note

The market was in a holiday mood.

Drugs IPOs Depend on Deals

Drugs IPOs Depend on Deals

Biotech IPOs that have relationships with established drug companies will do better than those going it alone.